Pharmaceuticals

Generic Drug Manufacturing Unit at pharma park at Kakkanad, Kochi
Contract Research and Manufacturing Organization (CRAMO) at Thiruvananthapuram:

Generic Drug Manufacturing Unit at pharma park at Kakkanad, Kochi

 

  • Generic drugs contain the same active ingredients, in the very same strength, as brand-name drugs. When a medicine is first developed, the pharmaceutical company that discovers and markets it receives a patent on its new drug. The patent usually lasts for 20 years, to give the originating company a chance to recoup its research investment. After the patent expires, a generic version of the drug may become available. Generics are marketed under the drug’s chemical, or "generic," name and meet the same Drug regulator quality and effectiveness standards as the original.

  • Brand-name manufacturers charge more in the India and elsewhere in the world. due to drug price deregulation. The high costs of drug research and marketing, which generic manufacturers don't have, drive up their pricing. However, generic manufacturers keep prices.low by avoiding advertising cost

  • Generic Drug Manufacturing unit aims to set up a manufacturing unit for generic drugs, such as antibiotics, antivirals, antifungals, and anti-inflammatory agents, at the proposed pharma park at Kakkanad, Kochi. The project brief is to produce high-quality and affordable medicines for the domestic and export markets, leveraging the existing petrochemical and chemical industries in Kochi.

 

Investment Avenues

  • Generic Drug Manufacturing Plant: Investment in developing state-of-the-art generic drug manufacturing facilities
  • Research & Development: Investment in research and development to
    produce high-quality, cost-effective generic drugs.
  • Logistics & Supply Chain: Investment in developing a robust logistics and
    supply chain infrastructure for efficient distribution of generic drugs.
  • Technology: Investing in advanced technologies for improved production,
    quality control and process efficiency.

 

Estimated Project Cost

~Rs 100 Cr

Status of the project 

The proposed Pharma Parks is expected to be operationalized by 2024

Policy support

All the incentives appliable under Kerala Industrial policy 2023

Nodal Department

Department of Industries and Commerce, Government of
Kerala, and Kerala State Industrial Development Corporation

Contacts

Managing Director
Kerala State Industrial Development Corporation Ltd.
T.C. XI/266, Keston Road, Kowdiar, Thiruvananthapuram-695 003
Ph: +91-471-2318922 (EPABX)
Fax: 0471-2315893
Email: ipksidc@ksidcmail.org / enquiry@ksidcmail.or

 

Impact On The Economy

The growth of the IT sector has had a substantial impact on Kerala's economy. It has created numerous job opportunities, contributing to reduced unemployment rates. Additionally, the state's IT exports have been steadily increasing, adding to its revenue. As IT companies and startups flourish, they also attract investment, thereby further stimulating the economy.Kerala's IT sector is not just about software services; it has diversified into various niches. Some notable sectors include healthcare IT, cybersecurity, fintech, and e-governance. These niche areas cater to both domestic and international markets, generating revenue and employment opportunities.

rightLeaf

Get to Know Us: Kerala's Investment Destination of Choice.

Exploring Kerala: Your Investment Journey Begins Here

knowUsPic1
KSIDC

Our vision at Invest Kerala is to see the state emerge as a beacon of economic vitality and innovation on both national and global fronts. We aspire to create an environment where every investor's dreams can take root

Read More

Contract Research and Manufacturing Organization(CRAMO)at Thiruvananthapuram:

 

  • CRAMS (Contract Research And Manufacturing Services) is one of the fastest growing segments in the pharmaceutical and biotechnology industry. It pertains to outsourcing research services/ manufacturing products to low-cost providers with world class standards, in line with international regulatory norms like the USFDA, Australian-TGA, UKMCA, and EMEA. Pharmaceutical multinationals have traditionally been outsourcing manufacture of intermediates, API’s and formulations

  • Increasing costs of R&D, coupled with low productivity and poor bottom lines, have forced major pharmaceutical companies worldwide to outsource part of their research and manufacturing activities to low-cost countries like INDIA. India soffers significant cost advantages over mature manufacturing hubs in Europe and North America. India has already emerged as one of the leading cost-competitive and quality manufacturing hubs for many global players including big pharma companies.

  • Contract Research and Manufacturing Organization (CRAMO) at Thiruvananthapuram aims to establish a CRAMO that offers services such as drug discovery, clinical trials, formulation development, analytical testing, and regulatory compliance, at Thiruvananthapuram, the capital city of Kerala. The project brief is to provide end-to-end solutions for the pharmaceutical and biotechnology industry, leveraging the existing research and innovation ecosystem in Thiruvananthapuram

 

Investment Avenues

In-house Contract Research: Development and validation of non-infringing
or novel formulation technology with confidential technology transfer.

  • Contract Manufacturing: Production of customer-defined products under
    strict confidentiality.
  • Contract Research and Manufacturing: Formulation design, analytical and
    stability data production, and manufacturing upscaling based on customer
    needs.

Estimated Project Cost

~Rs 200 Cr

Status of the project 

Many State based Private Organizations, Medical Institutes,Biotechnology institutes and Pharmaceutical Institutes are offering Contract Research and Manufacturing services in
the state

Policy support

All the incentives appliable under Kerala Industrial policy 2023

Nodal Department

Drug Control Department, Department of Industries and
Commerce, Government of Kerala, and Kerala State Industrial Development Corporation

Contacts

Managing Director
Kerala State Industrial Development Corporation Ltd.
T.C. XI/266, Keston Road, Kowdiar, Thiruvananthapuram-695 003
Ph: +91-471-2318922 (EPABX)
Fax: 0471-2315893
Email: ipksidc@ksidcmail.org / enquiry@ksidcmail.or

 

Impact On The Economy

The growth of the IT sector has had a substantial impact on Kerala's economy. It has created numerous job opportunities, contributing to reduced unemployment rates. Additionally, the state's IT exports have been steadily increasing, adding to its revenue. As IT companies and startups flourish, they also attract investment, thereby further stimulating the economy.Kerala's IT sector is not just about software services; it has diversified into various niches. Some notable sectors include healthcare IT, cybersecurity, fintech, and e-governance. These niche areas cater to both domestic and international markets, generating revenue and employment opportunities.

rightLeaf

Get to Know Us: Kerala's Investment Destination of Choice.

Exploring Kerala: Your Investment Journey Begins Here

knowUsPic1
KSIDC

Our vision at Invest Kerala is to see the state emerge as a beacon of economic vitality and innovation on both national and global fronts. We aspire to create an environment where every investor's dreams can take root

Read More

Last Updated on: 17 July 2024സന്ദ൪ശകരുടെ എണ്ണം : 3056822